Wednesday, January 28, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Arrow Electronics Stock: An Undervalued Play in Tech Distribution?

Dieter Jaworski by Dieter Jaworski
September 13, 2025
in Analysis, Earnings, Semiconductors, Tech & Software, Value & Growth
0
Arrow Stock
0
SHARES
143
VIEWS
Share on FacebookShare on Twitter

While the broader technology sector grapples with inventory gluts and tepid industrial demand, Arrow Electronics is demonstrating unexpected resilience. The technology distributor appears poised for a significant operational turnaround, though investor concerns about margins continue to create a cloud of uncertainty. Can anticipated growth figures ultimately overshadow these near-term worries?

A Compelling Valuation Story Emerges

A compelling valuation gap is at the heart of the investment thesis for Arrow Electronics. The company’s current multiples present a stark contrast to many of its technology peers. With a price-to-earnings (P/E) ratio of just 9.2, the distributor trades at a substantial discount to Micron Technology (21.0) and even slightly below its direct competitor, Avnet (10.1). The disparity becomes even more pronounced when examining the price-to-sales (P/S) ratio. While Micron carries a lofty P/S of 5.0, both Arrow and Avnet are valued at a mere 0.2 times sales.

The rationale for choosing Arrow over its rivals is supported by a recent Trefis analysis, which projects the company will outperform both competitors. The forecast calls for a 2.2 percent return over the coming three years. Both Arrow and Avnet are expected to achieve an annual revenue growth rate of 1.6 percent during this period.

Is the Market Overlooking a Recovery?

Following two challenging years of declining sales, 2025 is projected to be a year of recovery. Analysts at S&P Global anticipate a robust 9 percent increase in total revenue, pushing it to $30 billion. A particularly encouraging sign is the expected performance of the Components segment, which accounts for approximately 70 percent of total sales. After suffering declines of 21 percent in 2024 and 12 percent in 2023, this critical division is finally forecast to grow by 6 percent.

Should investors sell immediately? Or is it worth buying Arrow?

This positive trend is already finding support in recent quarterly results. In its July report, Arrow posted revenue of $7.6 billion, exceeding the high end of its guidance and showing strong sequential and year-over-year growth. However, the market reaction was negative, with the stock shedding nearly 10 percent after the release, as investor focus zeroed in on margin pressures and a negative operating cash flow.

Growth Drivers and Market Mispricing

The current stock valuation may not be fully accounting for this impending recovery narrative. The recent quarterly performance revealed powerful underlying trends: the Global Components division advanced by 5 percent, but the Enterprise Computing Solutions segment exploded with 23 percent growth. Although the operating margin contracted from 3.8 percent to 2.8 percent, this pressure could soon reverse amidst rising sales volumes.

For investors, the central question is whether the market is myopically focused on short-term margin fears at the expense of recognizing long-term potential. With a market capitalization of $6.8 billion against annual revenue of $27.8 billion, Arrow appears far from expensive. The stock currently trades a full 14 percent below its 52-week high, potentially offering a timely opportunity to position for a growth turnaround before the broader market takes notice.

Ad

Arrow Stock: Buy or Sell?! New Arrow Analysis from January 28 delivers the answer:

The latest Arrow figures speak for themselves: Urgent action needed for Arrow investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 28.

Arrow: Buy or sell? Read more here...

Tags: Arrow
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Hercules Capital Stock
Analysis

Hercules Capital Expands Biotech Lending Portfolio with Strategic Deals

January 28, 2026
Viking Therapeutics Stock
Analysis

Management’s Bet on Viking Therapeutics: Stock Options Signal Long-Term Confidence

January 28, 2026
Vulcan Energy Stock
Analysis

Vulcan Energy’s Path to Production: Technical Milestones and Market Focus

January 28, 2026
Next Post
Angel Oak Mortgage Stock

Angel Oak Mortgage's Strategic Partnership Nears Critical Juncture

Ryerson Stock

Ryerson Stock Tests Critical Technical Threshold Amid Mixed Signals

Opendoor Stock

Leadership Shakeup Sends Opendoor Shares on a Wild Ride

Recommended

JetBlue Airways Stock

Can Strategic Shifts Reverse JetBlue’s Fortunes?

3 months ago
Vanguard Information Technology Index Fund ETF Shares Stock

Tech Sector Surges as AI Investments Drive Record Performance

5 months ago
Automotive Trading online

Title Arson Attack Halts Production at Tesla Factory in Berlin

2 years ago
NextCure  Stock

NextCure Shares Extend Biotech Sector Rally

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Vulcan Energy’s Path to Production: Technical Milestones and Market Focus

US Mining ETF Approaches All-Time High on Policy and Price Surge

Broadcom’s AI Leadership Gains Further Validation

Synopsys Sets Date for First Quarter 2026 Financial Report

Navigating India’s Growth Story: A Deep Dive into the iShares MSCI India ETF

U.S. Secures Critical Minerals Supply with Multi-Billion Dollar Investment in USA Rare Earth

Trending

Hercules Capital Stock
Analysis

Hercules Capital Expands Biotech Lending Portfolio with Strategic Deals

by Robert Sasse
January 28, 2026
0

Hercules Capital, a leading specialty finance company, has significantly increased its exposure to the life sciences sector...

Viking Therapeutics Stock

Management’s Bet on Viking Therapeutics: Stock Options Signal Long-Term Confidence

January 28, 2026
Bitcoin Stock

Bitcoin’s Price Consolidation Persists Amid Mixed Signals

January 28, 2026
Vulcan Energy Stock

Vulcan Energy’s Path to Production: Technical Milestones and Market Focus

January 28, 2026
SPDR® S&P Metals and Mining ETF Stock

US Mining ETF Approaches All-Time High on Policy and Price Surge

January 28, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Hercules Capital Expands Biotech Lending Portfolio with Strategic Deals
  • Management’s Bet on Viking Therapeutics: Stock Options Signal Long-Term Confidence
  • Bitcoin’s Price Consolidation Persists Amid Mixed Signals

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com